TEVOGEN BIO HOLDINGS INC (TVGN)

US88165K1016 - Common Stock

1.03  -0.02 (-1.9%)

Premarket: 1.03 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.00
Operating Expenses
2.27M950.00K180.00KN/A
Research and Development
N/A5.77M2.96MN/A
Selling, General, and Administrative Expenses
2.27M950.00K180.00KN/A
Operating Income
-2.27M-950.00K-180.00K0.00
Interest Income/Expense
-277.80K5.36M150.00KN/A
Other Income/Expense
-250.00K0.000.00N/A
Non Recurring Items
2.73MN/AN/AN/A
Income Before Taxes
-67.30K4.41M-30.00KN/A
Net Income
-67.30K4.41M-30.00KN/A
EBITDA
N/A-859.60K-170.60KN/A
 
Per Share Data
EPS Diluted Total Ops
0.000.090.00N/A
 
Statistics

All data in USD

Charts